Asset Details
Do you wish to reserve the book?
mRNA based vaccines and therapeutics for parasitic infections: a comprehensive review
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
mRNA based vaccines and therapeutics for parasitic infections: a comprehensive review
Do you wish to request the book?
mRNA based vaccines and therapeutics for parasitic infections: a comprehensive review
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
mRNA based vaccines and therapeutics for parasitic infections: a comprehensive review
2025
Overview
The success of mRNA vaccines during the COVID-19 pandemic has revealed a revolutionary platform for addressing neglected parasite zoonosis, which represent a continual and significant threat to world health, especially in resource-constrained settings. The current review consolidates recent progress in the development of mRNA-based treatments, vaccines, and diagnostic ways for these pathogens. We elucidate how customized delivery platforms, particularly lipid nanoparticles, augment the stability and immunogenicity of parasite-derived mRNA cargo by safeguarding it from degradation and promoting uptake by antigen-presenting cells. Our findings suggest that mRNA technology provides a particularly adaptable strategy to targeting complicated parasite life cycles and efficiently modulating host immune responses. However, important challenges, such as cold-chain logistics, scalability, clinical trial design for diverse populations, and managing public opinion, must be solved beforehand. Future initiatives must priorities the creation of thermostable formulations and effective community participation strategies. Finally, this review emphasizes that mRNA-based interventions represent a promising, albeit challenging, frontier in the fight against parasitic diseases, urging a collaborative cross-disciplinary effort to translate this potential into tangible health breakthroughs for the world’s most vulnerable populations.
Graphical abstract
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
Advanced diagnostic and therapeutic strategies
/ Animals
/ Chemistry and Materials Science
/ COVID-19
/ COVID-19 - prevention & control
/ Humans
/ Lipids
/ mRNA
/ Parasitic Diseases - immunology
/ Parasitic Diseases - prevention & control
/ Parasitic Diseases - therapy
/ Review
/ RNA, Messenger - therapeutic use
/ Vaccines
/ Zoonoses
/ Zoonosis
